Episode 344: Big Data Leads to Big Breakthroughs in MS with Professor Sergio Baranzini
RealTalk MS1 Huhti 2024

Episode 344: Big Data Leads to Big Breakthroughs in MS with Professor Sergio Baranzini

If you're a regular listener, you've probably heard me say that the pace of scientific discovery is moving faster than ever before. Or you may have heard the National MS Society remind us that we've seen as many advances in MS research in the past 5 years as we have in the previous 70 years. Have you ever wondered why?

A major driver of this acceleration of discovery is the technology that allows scientists to analyze massive amounts of information looking for relationships or identifying characteristics that, without this technology, would be impossible to see.

This category of tech is commonly referred to as big data. And we're closer than we've ever been to understanding the biological complexities of multiple sclerosis because we've learned to harness the computing power that allows scientists to discover those very small needles among those very large haystacks.

My guest in this episode is Professor Sergio Baranzini. Professor Baranzini is this year's recipient of the Barancik Prize for Innovation in MS Research and he's someone who has successfully leveraged big data to drive big, game-changing discoveries in multiple sclerosis.

We'll also share some good news about MS research funding from the federal government.

We'll review newly published results from a study that has identified 3 subtypes of MS, each with a different disease trajectory.

We'll share evidence from a study that focused on whether people over the age of 50 with nonactive MS should discontinue their disease-modifying therapy.

And we'll tell you about the Canadian regulatory approval of a software-based medical device that can monitor MS disease activity by tracking eye movement -- all from an iPad that people with MS can use at home.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: We're saluting Professor Sergio Baranzini, this year's winner of the Barancik Prize :22

Congress provides $20 million in FY2024 funding for the MS Research Program 1:57

A German research team has identified 3 subtypes of MS based on their unique immune cell signature found in a blood sample 4:10

A French research team focused their study on whether people over the age of 50 with nonactive MS should discontinue their DMT. Here's what they discovered 8:58

Health Canada has approved ETNA-MS. A software-based medical device that can monitor MS disease activity by tracking eye movement 12:48

Professor Sergio Baranzini discusses how big data has fundamentally changed scientific research, and how he's using it to find cures for MS 16:44

Share this episode 32:03

Have you downloaded the free RealTalk MS app? 32:24

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/344

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

REGISTER for the MS Activist Rally
https://events.zoom.us/ev/Ame2jWSuHmriG94cyQmlWHr45mgnzxkDv8oMZRGsrS3ZxiSj5rro~Anqb3dHg3ewiz4KNHn2Ena4bgli_WXlza_zcygZN3GinnleB6rO15OCzGQ

STUDY: Multiple Sclerosis Endophenotypes Identified by High-Dimensional Blood Signatures are Associated with Distinct Disease Trajectories
https://science.org/doi/10.1126/scitranslmed.ade8560

STUDY: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older with Nonactive MS
https://jamanetwork.com/journals/jamaneurology/article-abstract/2816799

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 344
Guest: Professor Sergio Baranzini

Privacy Policy

Jaksot(504)

Episode 422: From ECTRIMS 2025 with Dr. Bruce Bebo and Kristine Werner Ozug

Episode 422: From ECTRIMS 2025 with Dr. Bruce Bebo and Kristine Werner Ozug

Last week, over 9600 MS researchers and clinicians gathered in Barcelona for the European Committee for Treatment and Research in Multiple Sclerosis annual scientific congress -- ECTRIMS 2025. Minut...

29 Syys 202523min

Episode 421: Optimizing Your Brain Health with Nurse Practitioner Erin Wilkinson

Episode 421: Optimizing Your Brain Health with Nurse Practitioner Erin Wilkinson

Happy birthday to us! RealTalk MS is 8 years old today! It's hard for me to believe that the podcast I launched in 2017, with the goal of one day reaching 300 listeners, today reaches thousands of peo...

22 Syys 202542min

Special Episode: Dr. Aaron Boster Explains MS Clinical Trials

Special Episode: Dr. Aaron Boster Explains MS Clinical Trials

You're living with MS, and maybe you're thinking about participating in an MS clinical trial. But how do they work? Are they safe? What's the difference between Phase 1, 2, and 3 trials? What are the ...

17 Syys 202533min

Episode 420: A DIY Kit for Improving Your MS Journey with Julie Polisena

Episode 420: A DIY Kit for Improving Your MS Journey with Julie Polisena

Disease-modifying therapies are the cornerstone of MS treatment, but they're not the only piece of the puzzle. Beyond prescription medications, self-care that includes making healthy lifestyle choices...

15 Syys 202534min

Episode 419: A Whole-Person Health Approach to MS Care with Dr. Lynne Shinto

Episode 419: A Whole-Person Health Approach to MS Care with Dr. Lynne Shinto

Some people living with MS adhere to a treatment plan based exclusively on what we might consider traditional medicine. Others opt for alternative treatments. And, still, others take a whole-person he...

8 Syys 202533min

Episode 418: The Importance of Developing a Growth Mindset When You're Living With MS with Dr. Mirian Franco

Episode 418: The Importance of Developing a Growth Mindset When You're Living With MS with Dr. Mirian Franco

Living with MS means living with uncertainty, possible physical disability or cognitive dysfunction, bouts of crushing fatigue, mood changes, and let's not forget the very real irritation of well-mean...

1 Syys 202535min

Episode 417: Music and the Body with Emmy Award-Winning Composer Jeff Beal

Episode 417: Music and the Body with Emmy Award-Winning Composer Jeff Beal

If you've watched the critically acclaimed series, House of Cards, on Netflix, or the OCD detective series, Monk, on the USA Network, you've already listened to some of five-time Emmy award-winning co...

25 Elo 202532min

Episode 416: The Updated McDonald Diagnostic Criteria for MS with Dr. Andrew Solomon

Episode 416: The Updated McDonald Diagnostic Criteria for MS with Dr. Andrew Solomon

Since 2001, clinicians have relied on the McDonald Diagnostic Criteria as the gold standard for diagnosing someone with multiple sclerosis. As science continues to add to our understanding of MS, the ...

18 Elo 202527min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
rss-pitaisko-erota
rss-narsisti
puhu-muru
rss-kuumilla-aalloilla
rss-pt-paahtio
meditaatiot-suomeksi
selviytyjat-tarinoita-elamasta
terapiassa
fitnesskulmapodcast
junnut-pelissa
rss-nautinto
audio-sport-juoksu
fitnessvastaanotto
rss-addiktit
rss-seuraava-potilas